In the world of biologics, MedImmune has established itself as a true visionary,
with one of the most robust pipelines in the biopharmaceutical industry. From
groundbreaking research and development, to state-of-the-art manufacturing, to
product commercialization, every day we're touching lives. We're proudly united
by the spirit of innovation, the heart of inspiration, and the strength of
integration, as we advance science for better health.
The value of health. The promise of Biotech. The purpose of MedImmune.
Spirit of Innovation
Renowned for originality and creativity, and backed by a 20-year heritage,
MedImmune is synonymous with intelligent risk-taking and accountability. We
strive to address unmet medical needs by developing novel proprietary products
and cutting-edge technologies. By incorporating translational sciences,
otherwise known as "customized medicine," in an increasing number of our
clinical programs, MedImmune is continually striving toward the future.
Heart of Inspiration
Today's MedImmune offers a promising future. Our more than 3,000 employees are
dedicated to helping people live better lives. We are developing new
therapeutic and preventive medicines that hold tremendous potential for
patients around the globe in the areas of infectious disease, oncology,
respiratory disease and inflammation, cardiovascular/gastrointestinal disease,
and neuroscience. We're committed to making a difference in science, in the
lives of patients, and in the communities in which we operate.
Strength of Integration
With locations in the United States, the United Kingdom, and the Netherlands,
we all work together toward one goal: helping people live healthier, longer,
and more satisfying lives. Established in 2007 as the global biologics business
for AstraZeneca, we have continued to advance our R&D portfolio and expand
our headcount, research capability, and manufacturing facilities. We are a
catalyst for change, forging ahead with a spirit of collective creativity and